Quarterly report pursuant to Section 13 or 15(d)

INSTALLMENT PAYMENTS - LICENSES

v3.21.2
INSTALLMENT PAYMENTS - LICENSES
9 Months Ended
Sep. 30, 2021
INSTALLMENT PAYMENTS - LICENSES  
INSTALLMENT PAYMENTS - LICENSES

NOTE 10. INSTALLMENT PAYMENTS — LICENSES

The following tables show the details of the Company’s installment payments – licenses for the periods presented:

    

September 30, 2021

    

    

    

Anti-Itch

    

($in thousands)

Ximino 1

Accutane 2

Product 3

Total

Installment payments - licenses, short-term

$

2,000

$

2,000

$

1,000

$

5,000

Less: imputed interest

 

(472)

 

(84)

 

(11)

 

(567)

Sub-total installment payments - licenses, short-term

$

1,528

$

1,916

$

989

$

4,433

Installment payments - licenses, long-term

$

3,000

$

1,000

$

$

4,000

Less: imputed interest

 

(428)

 

(33)

 

 

(461)

Sub-total installment payments - licenses, long-term

$

2,572

$

967

$

$

3,539

Total installment payments - licenses

$

4,100

$

2,883

$

989

$

7,972

    

December 31, 2020

    

    

    

Anti-Itch

    

($in thousands)

Ximino 1

Accutane 2

Product 3

Total

Installment payments - licenses, short-term

$

2,000

$

500

$

2,800

$

5,300

Less: imputed interest

 

(602)

 

(122)

 

(54)

 

(778)

Sub-total installment payments - licenses, short-term

$

1,398

$

378

$

2,746

$

4,522

Installment payments - licenses, long-term

$

5,000

$

3,000

$

1,000

$

9,000

Less: imputed interest

 

(775)

 

(88)

 

 

(863)

Sub-total installment payments - licenses, long-term

$

4,225

$

2,912

$

1,000

$

8,137

Total installment payments - licenses

$

5,623

$

3,290

$

3,746

$

12,659

Note 1: Imputed interest rate of 11.96% and maturity date of July 22, 2024.

Note 2: Imputed interest rate of 4.03% and maturity date of July 29, 2023.

Note 3: Imputed interest rate of 4.25% and maturity date of January 1, 2022.